IP Library › Assignment 042802/0375
Patent Assignment
Reel/Frame 042802/0375

Change of Name

Recorded: 2017-06-23 Pages: 2
Assignor
Assignee
ARBUTUS BIOPHARMA CORPORATION
100 - 8900 GLENLYON PARKWAY, BURNABY, BRITISH COLUMBIA, V5J 5J8, CANADA
Covered Properties (3)
Site-Specific Delivery of Nucleic Acids by Combining Targeting Ligands with Endosomolytic Components
Patent: 8,575,123 →
Application: 12/936,961 →
Publication: US 2011/0123520
Site Specific Delivery of Nucleic Acids by Combining Targeting Ligands with Endosomolytic Components
Patent: 9,345,780 →
Application: 14/043,682 →
Publication: US 2014/0256785
Site-Specific Delivery of Nucleic Acids by Combining Targeting Ligands with Endosomolytic Components
Patent: 9,895,448 →
Application: 15/133,010 →
Publication: US 2016/0367687
Related Assignments (5)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 13, 2014
From: MANOHARAN, MUTHIAH; RAJEEV, KALLANTHOTTATHIL G.; BUTLER, DAVID; JAYARAMAN, MUTHUSAMY
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 034167/0276 →
Assignment of Assignor's Interest Nov 13, 2014
From: ALNYLAM PHARMACEUTICALS, INC.
To: TEKMIRA PHARMACEUTICALS CORPORATION
Reel/Frame 034167/0286 →
Assignment of Assignor's Interest May 19, 2016
From: ALNYLAM PHARMACEUTICALS, INC.
To: TEKMIRA PHARMACEUTICALS CORPORATION
Reel/Frame 038643/0790 →
Assignment of Assignor's Interest Jun 23, 2017
From: MANOHARAN, MUTHIAH; RAJEEV, KALLANTHOTTATHIL G.; BUTLER, DAVID; JAYARAMAN, MUTHUSAMY
To: ALNYLAM PHARMACEUTICALS, INC.
Reel/Frame 042802/0370 →
Merger and Change of Name Jul 27, 2018
From: PROTIVA BIOTHERAPEUTICS INC.; ARBUTUS BIOPHARMA CORPORATION
To: ARBUTUS BIOPHARMA CORPORATION
Reel/Frame 046640/0764 →